Latest maintenance strategies in multiple myeloma
Latest maintenance strategies in multiple myeloma
Front-line combinations in multiple myeloma: Highlights from EHA 2017
Lenalidomide with CD19 antibodies in L-MIND
Denosumab or zoledronic acid for bone disease in multiple myeloma
Extended followup indicates daratumumab with bortezomib and dexamethasone for relapsed MM
Impact of mutational profile at diagnosis for MDS/CML
Delayed infection exposure as a trigger for childhood ALL
Triplet therapy for all comers in the CLL-BAG trial
Safety and efficacy of blinatumomab for acute lymphoblastic leukaemia
Blood thinners a risk with cancer-associated venous thromboembolism
FDG-PET guidance allows substantial chemoreduction in Hodgkin lymphoma
ZUMA 1: CD19 CAR T cells for refractory NHL